ID

23231

Beschrijving

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00412997

Link

https://clinicaltrials.gov/show/NCT00412997

Trefwoorden

  1. 29-06-17 29-06-17 -
Geüploaded op

29 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Tumors NCT00412997

Eligibility Tumors NCT00412997

  1. StudyEvent: Eligibility
    1. Eligibility Tumors NCT00412997
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with either a) histologically-confirmed, advanced solid tumors whose disease has progressed despite standard therapy or for whom no standard therapy exists, or b) cytopathologically confirmed cutaneous t-cell lymphoma (ctcl) whose disease has progressed despite standard therapy or for whom no standard therapy exists. inclusion is irrespective of stage of disease or extent of prior therapy.
Beschrijving

Standard therapy Solid tumour Advanced | Disease Progression | Standard therapy Lacking | Standard therapy Cutaneous T-Cell Lymphoma | Disease Progression | Standard therapy Lacking

Datatype

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0280100
UMLS CUI [1,3]
C0205179
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C2936643
UMLS CUI [3,2]
C0332268
UMLS CUI [4,1]
C2936643
UMLS CUI [4,2]
C0079773
UMLS CUI [5]
C0242656
UMLS CUI [6,1]
C2936643
UMLS CUI [6,2]
C0332268
world health organization (who) performance status of ≤ 2
Beschrijving

WHO performance status scale

Datatype

boolean

Alias
UMLS CUI [1]
C1298650
patients must have the adequate laboratory values
Beschrijving

Laboratory Results

Datatype

boolean

Alias
UMLS CUI [1]
C1254595
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a history of primary cns tumors
Beschrijving

Central Nervous System Neoplasms, Primary

Datatype

boolean

Alias
UMLS CUI [1]
C0751620
patients with any history of brain metastases
Beschrijving

Metastatic malignant neoplasm to brain

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
patients with any peripheral neuropathy ≥ ctcae grade 2
Beschrijving

Peripheral Neuropathy CTCAE Grades

Datatype

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
patients with unresolved diarrhea ≥ ctcae grade 2
Beschrijving

Diarrhea Unresolved CTCAE Grades

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011991
UMLS CUI [1,2]
C0443342
UMLS CUI [1,3]
C1516728
impairment of cardiac function
Beschrijving

Decreased cardiac function

Datatype

boolean

Alias
UMLS CUI [1]
C0232166
impairment of gastrointestinal (gi) function or gi disease
Beschrijving

Gastrointestinal function Impairment | Gastrointestinal Diseases

Datatype

boolean

Alias
UMLS CUI [1,1]
C0516983
UMLS CUI [1,2]
C0221099
UMLS CUI [2]
C0017178
liver or renal disease
Beschrijving

Liver diseases | Kidney Diseases

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
other protocol-defined inclusion/exclusion criteria may apply
Beschrijving

Clinical Trial Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563

Similar models

Eligibility Tumors NCT00412997

  1. StudyEvent: Eligibility
    1. Eligibility Tumors NCT00412997
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Standard therapy Solid tumour Advanced | Disease Progression | Standard therapy Lacking | Standard therapy Cutaneous T-Cell Lymphoma | Disease Progression | Standard therapy Lacking
Item
patients with either a) histologically-confirmed, advanced solid tumors whose disease has progressed despite standard therapy or for whom no standard therapy exists, or b) cytopathologically confirmed cutaneous t-cell lymphoma (ctcl) whose disease has progressed despite standard therapy or for whom no standard therapy exists. inclusion is irrespective of stage of disease or extent of prior therapy.
boolean
C2936643 (UMLS CUI [1,1])
C0280100 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C2936643 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0079773 (UMLS CUI [4,2])
C0242656 (UMLS CUI [5])
C2936643 (UMLS CUI [6,1])
C0332268 (UMLS CUI [6,2])
WHO performance status scale
Item
world health organization (who) performance status of ≤ 2
boolean
C1298650 (UMLS CUI [1])
Laboratory Results
Item
patients must have the adequate laboratory values
boolean
C1254595 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central Nervous System Neoplasms, Primary
Item
patients with a history of primary cns tumors
boolean
C0751620 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
patients with any history of brain metastases
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy CTCAE Grades
Item
patients with any peripheral neuropathy ≥ ctcae grade 2
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Diarrhea Unresolved CTCAE Grades
Item
patients with unresolved diarrhea ≥ ctcae grade 2
boolean
C0011991 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Decreased cardiac function
Item
impairment of cardiac function
boolean
C0232166 (UMLS CUI [1])
Gastrointestinal function Impairment | Gastrointestinal Diseases
Item
impairment of gastrointestinal (gi) function or gi disease
boolean
C0516983 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial